SION Latest Headlines

Sionna Therapeutics Faces Scrutiny After Phase 2a Trial Miss—Shareholder Investigation Launched

Market Chameleon (Wed, 12-Aug 10:32 AM)

Sionna Therapeutics Re-Evaluates Cystic Fibrosis Drug Programs After Mixed Trial Results—Dual Combination Therapy Takes Spotlight

Market Chameleon (Tue, 11-Aug 9:55 AM)

Sionna Therapeutics Ends Phase 2a SION-719 Development and Focuses on SION-451 Dual Combinations for Cystic Fibrosis

Market Chameleon (Mon, 10-Aug 7:28 AM)

Sionna’s Cash Position Remains Strong as Key Cystic Fibrosis Data Readouts Approach

Market Chameleon (Thu, 6-Aug 9:46 AM)